Immunogenic Properties of a Bovine Herpesvirus-1 (BHV-1) Recombinant Expressing Major Pseudorabies Virus (PrV) Glycoproteins in Combination

Journal of Veterinary Medical Science

Volumn 62, Issue 8, 2000, Pages 849-859

  Ikeda, Yukinori ^a   Shibata, Isao ^b   Xuan, Xuenan ^c   Matsumoto, Yasunobu ^a   Otsuka, Haruki ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b Zen noh Institute of Animal Health   (Japan)

^c OBIHIRO UNIVERSITY OF AGRICULTURE AND VETERINARY MEDICINE   (Japan)

Author keywords

Aujeszky's disease; BHV 1; Glycoprotein; PrV; Recombinant vaccine

Indexed keywords

BOVINAE; BOVINE HERPESVIRUS 1; HERPESVIRIDAE; HERPESVIRUS 1; SUID HERPESVIRUS 1;

DNA VACCINE; LIVE VACCINE; PSEUDORABIES VIRUS GLYCOPROTEINS; RECOMBINANT DNA; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; BIOSYNTHESIS; CATTLE; CELL CULTURE; DELAYED HYPERSENSITIVITY; GENETICS; IMMUNOLOGY; INFECTIOUS BOVINE RHINOTRACHEITIS VIRUS; LYMPHOCYTE ACTIVATION; MOUSE; PSEUDORABIES HERPETOVIRUS; SWINE; SWINE DISEASE; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, VIRAL; BLOTTING, WESTERN; CATTLE; CELLS, CULTURED; DNA, RECOMBINANT; HERPESVIRUS 1, BOVINE; HERPESVIRUS 1, SUID; HYPERSENSITIVITY, DELAYED; LYMPHOCYTE ACTIVATION; MICE; SWINE; SWINE DISEASES; VACCINES, ATTENUATED; VACCINES, DNA; VIRAL ENVELOPE PROTEINS;

EID: 0034251722     PISSN: 09167250     EISSN: None     Source Type: Journal    
DOI: 10.1292/jvms.62.849     Document Type: Article

References (34)

1. Andries, K., Pensaert, M. B. and Vandeputte, J. 1978. Effect of experimental infection with pseudorabies (Aujeszky's disease) virus on pigs with maternal immunity from vaccinated sows. Am. J. Vet. Res. 39: 1282-1285.
2. Arellani, P. E., Morrison, R. B., Moritor, T. W. and Thawley, D. G. 1992. High- and low-challenge exposure doses used to compare intranasal and intramuscular of administration of pseudorabies virus vaccine in passively immune pigs. J. Am. Vet. Med. Assoc. 5: 685-591.
3. Bouma, D., De Jong, M. C. M. and Kimman, T. G. 1997. The influence of maternal immunity on the transmission of pseudorabies virus and on the effectiveness of vaccination. Vaccine 15: 287-294.
4. Chappnis, G., Fargeaud, D. and Brun, A. 1989. Industrial production and control of asubunit vaccine against Aujeszky's disease, pp. 67-78. In: Vaccination and Control of Aujeszky's Disease (Van Oirschot, J. T. ed.), Kluwer Academic Publishers.
5. Derbyshire, J. B. and Caplan, B. A. 1976. The isolation and characterization of a strain of infectious bovine rhinotracheitis virus from stillbirth in swine. Can. J. Comp. Med. 40: 252-256.
6. Dnaldson, A. I., Wardley, R. C., Martin, S. and Harkness, J. W. 1985. Influence of vaccination on Aujeszky's disease virus and transmission. Vet. Rec. 115: 121-124.
7. Gibbs, E. P. J. and Rweyemamu, M. M. 1977. Bovine herpes-virus. 1. Bovine herpes I. Vet. Bull. 47: 317-343.
8. Hutton, J. C., Penn, E. J. and Peshavaria, M. 1982. Isolation and characterization of insulin secretary granules from a rat aslet cell tumor. Diabetologia 23: 365-373.
9. Ishii, H., Kobayashi, Y., Kuroki, M. and Kodama, Y. 1988. Protection of mice from lethal infection with Aujeszky's disease virus by immunization with purified gVI. J. Gen. Virol. 69: 1411-1414.
10. Kimman, T. G. 1993. Characterization of the pseudorabies virus-specific immunoglobulin M response and evaluation of its diagnostic use in pigs with preexisting immunity to the virus. J. Clin. Microbiol. 31: 2309-2314.
11. Kit, M., Kit, S., Little, S. P., DiMarchi, R. D. and Gale, C. 1991. Bovine herpesvirus-1 (infectious bovine rhinotracheitis virus) -based viral vector which expresses foot and mouse disease epitopes. Vaccine 9: 564-572.
12. Kit, S., Kit, M., DiMarchi, R. D., Little, S. P. and Gale, C. 1991. Modified live infectious bovine rhinotracheitis virus vaccine expressing monomer and dimer forms of foot and mouse disease capsid protein epitope on surface of hybrid virus particle. Arch. Virol. 120: 1-7.
13. Kluge, J. P., Beran, G. W., Hill, H. T. and Platt, K. B. 1992. Pseudorabies (Aujeszky's disease), pp. 312-323. In: Disease of Swine, 7th ed. Leman, A. D., Straw, B. E., Mengeling, W. L. D'Allaire, S. and Taylor, D. J. (eds), Iowa State University Press, Ames, IA.
14. Laemmi, U. K. 1970. Cleavage of stractural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.) 227: 680-685.
15. Lupton, H. W., Barens, H. J. and Reed, D. E. 1980. Evaluation of the rabbit as laboratory model of infectious bovine rhinotracheitis virus infection. Cornell Vet. 70: 77-95.
16. Maes, R.K. and Shutz, J.C. 1983. Evaluation in swine at a subunit vaccine against pseudorabies. Am. J. Vet. Res. 44: 123-125.
17. Marchioli, C. C., Yancey, R. J. Jr., Wardley, R. C., Tormasen, D. R. and Post, L. E. 1987. A vaccine strain of pseudorabies virus with deletions in the thymidine kinase and glycoprotein X genes. Am. J. Vet. Res. 48: 1577-1583.
18. Marchioli, C. C., Yancey, J. Jr., Petrovskis, E. A., Timmins, J. G. and Post, L. E. 1987. Evaluation of pseudorabies virus glycoprotein gp50 as a vaccine for Aujeszky's disease in mice and swine: Expression by vaccinia virus and Chinese hamster ovary cells. J. Virol. 61: 3977-3982.
19. Matsuda-Tsuchida, A., Katayama, S., Okada, N., Okabe, T. and Sasaki, N. 1992. Protection from pseudorabies virus challenge in mice by a recombination of purified gII, gIII and gVI antigen. J. Vet. Med. Sci. 54: 447-452.
20. Mcfaland, M. D. and Hill, H. T. 1987. Vaccination of mice and swine with a pseudorabies mutant lacking thymidine kinase activity. Can. J. Vet. Virol. 51: 340-344.
21. McFerran, J. B., Dow, D. and McCracken, R. M. 1979. Experimental studies in weaned pigs with three vaccines against Aujeszky's disease. Comp. Immunol. Microbiol. Infect. Dis. 2: 327-334.
22. Mengeling, W.L. 1989. Latent infection and subsequent reactivation of pseudorabies virus in swine exposed to pseudorabies virus while nursing immune dams. Am. J. Vet Res. 10: 1658-1966.
23. Mohanty, S. B., Lillie, M. G., Corcelius, N. P. and Beck, J. D. 1972. Natural infection with infectious bovine rhinotracheitis virus in goats. J. Am. Vet. Med. Assoc. 160: 879-880.
24. Nelson, D. R., Mare, C. J. and Glock, R. D. 1972. Infectious bovine rhinotracheitis (herpes bovis) infection in swine. Am. J. Vet. Res. 33: 1209-1215.
25. Otsuka, H. and Xuan, X. 1996. Construction of bovine herpes-virus-1 (BHV-1) recombinants which express pseudorabies virus (PrV) glycoprotein gB, gC, gD and gE. Arch. Virol. 141: 57-71.
26. Otsuka, H., Xuan, X., Shibata, I. and Mon, M. 1996. Protective immunity of bovine herpesvirus-1 (BHV-1) recombinants which express pseudorabies virus (PrV) glycoprotein gB, gC, gD and gE. J. Vet. Med. Sci. 58: 819-824.
27. Pensaert, M. B., Smet, K. and Waele, K. 1990. Extent and duration of virulent virus excretion upon challenge of pigs vaccinated with different glycoprotein-deleted Aujeszky's disease vaccines. Vet. Microbiol. 22: 107-117.
28. Platt, K. B. 1984. The evaluation of a lectin-agarose based subunit vaccine and complementary diagnostic antigen for Aujeszky's disease (pseudorabies) in the pig. Vet. Microbiol. 9: 35-51.
29. Porter, D. D., Larsen, A. E. and Cox, N. A. 1975. Isolation of infectious bovine rhinotracheitis virus from Mustelidae (minks). J. Clin. Microbiol. 1: 112-113.
30. Riviere, M., Tartaglia, J., Perkus, M. E., Norton, E. K., Bongermino, C. M., Lacoste, F., Duret, C., Desmettre, P. and Paoletti, E. 1992. Protection of mice and swine from pseudorabies virus conferred by vaccinia virus-based recombinants. J. Virol. 66: 3424-3434.
31. Sabo, A. 1969. Persistence of per orally administered virulent pseudorabies virus in organisms of non-immune and immunized pigs. Acta Virol. 13: 269-277.
32. Schmid, D. S. and Pouse, B. T. 1992. The role of T cell immunity in control of herpes simplex virus. Curr. Top. Microbiol. Immunol. 179: 57-74.
33. Vannier, P. 1985. Experimental infection of fattening pigs with pseudorabies (Aujeszky's disease) virus: Efficacy of attenuated live- and inactivated virus vaccine in pigs with or without passive immunity. Am. J. Vet. Res. 46: 1498-1502.
34. Vannier, P., Hutet, E., Bourgueil, E. and Cariolet, R. 1991. Level of virulent virus excreted by infected pigs previously vaccinated with different glycoprotein deleted Aujeszky's disease vaccines. Vet. Microbiol. 29: 213-223.